Maat Pharma SA (MAAT) Stock Price & News

MAAT:EPA

Maat Pharma SA

1,08 €

-1,10%

(-0,012) 1D

11 նոյ, 15:09:05 GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for MAAT...

Open

1,09 €

High

1,10 €

Low

1,07 €

Mkt. cap

20,44 մլն

Avg. vol.

88,39 հզր

Volume

30,46 հզր

52-wk high

8,62 €

52-wk low

0,90 €

EPS

-1,93 €

Shares outstanding

18,86 մլն

No. of employees

Open

1,09 €

High

1,10 €

Low

1,07 €

Mkt. cap

20,44 մլն

Avg. vol.

88,39 հզր

Volume

30,46 հզր

52-wk high

8,62 €

52-wk low

0,90 €

EPS

-1,93 €

Shares outstanding

18,86 մլն

No. of employees

Related stocks

Ose Immunotherapeutics SA

1,73 €

+1,65%

News stories

From web sources and news partners

PR Newswire Canada

37 րոպե առաջ

NYSE Honors Those Who Have Served on Veterans Day: NYSE Content Update

Seeking Alpha

7 րոպե առաջ

Nasdaq tests 28K resistance zone as futures rebound past 200-DMA

Reuters

40 րոպե առաջ

Wall Street set for higher open as CoreWeave results temper AI spending concerns

markets.businessinsider.com

1 ժամ առաջ

Rantizo (Nasdaq: RNTZ) Advances U.S. Production of Heavy-Lift Autonomous Drones After $258.8 Million Acquisition, Targets California’s $61.2 Billion Agricultural Market

About Maat Pharma SA

CEO-

Employees60

Founded04 դեկ, 2014 թ.

Headquarters-

SectorHealth Care

Industry-

Websitemaatpharma.com

All values in EUR	2025 թ. սեպ	2025 թ. դեկ	2026 թ. մրտ	2026 թ. հնս
Revenue	1,05 մլն	1,05 մլն	539,50 հզր	539,50 հզր
Cost of goods sold	469,00 հզր	469,00 հզր	52,50 հզր	52,50 հզր
Cost of revenue	469,00 հզր	469,00 հզր	52,50 հզր	52,50 հզր
Research and development expenses	6,94 մլն	6,94 մլն	9,60 մլն	9,60 մլն
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,04 մլն	2,04 մլն	1,41 մլն	1,41 մլն
Operating expense	8,07 մլն	8,07 մլն	9,99 մլն	9,99 մլն
Total operating expenses	8,54 մլն	8,54 մլն	10,04 մլն	10,04 մլն
Operating income	-7,49 մլն	-7,49 մլն	-9,50 մլն	-9,50 մլն
Other non operating income	-31,50 հզր	-31,50 հզր	691,50 հզր	691,50 հզր
EBT including unusual items	-7,99 մլն	-7,99 մլն	-9,17 մլն	-9,17 մլն
EBT excluding unusual items	-7,99 մլն	-7,99 մլն	-9,17 մլն	-9,17 մլն
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-915,00 հզր	-915,00 հզր	-1,02 մլն	-1,02 մլն
Net income	-7,99 մլն	-7,99 մլն	-9,17 մլն	-9,17 մլն
Net profit margin	-761,85%	-761,85%	-1 698,89%	-1 698,89%
Earnings per share	-	-	-	-
Interest and investment income	-	-	41,00 հզր	41,00 հզր
Interest expense	-466,50 հզր	-466,50 հզր	-396,00 հզր	-396,00 հզր
Net interest expenses	-466,50 հզր	-466,50 հզր	-355,00 հզր	-355,00 հզր
Depreciation and amortization charges	-	-	-	-
EBITDA	-7,38 մլն	-7,38 մլն	-7,94 մլն	-7,94 մլն
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything